Covid-19-reserch-innovation

Newly published research from Peabody College of education and human development and the Christopher & Dana Reeve Foundation highlights the perspectives of the paralysis community on COVID-19 vaccine boosters. Among the key findings is evidence that individuals living with paralysis have specific safety concerns that should be addressed… Read More

The Department of Medicine, Health and Society will host a panel discussion, “The Viral Underclass: Pandemic Inequality from HIV/AIDS to COVID-19,” on Tuesday, Nov. 15, from 1:15 to 2:30 p.m. in Furman Hall, Room 114. Read More

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. Read More

Stacey M. Floyd-Thomas, E. Rhodes and Leona B. Carpenter Professor and associate professor of ethics and society, has edited and published Religion, Race, and COVID-19: Confronting White Supremacy in the Pandemic, an anthology exploring the countless challenges, racially charged acts, setbacks, triumphs and newfound hope through the eyes of individuals living through one of the most pressing, perplexing social crises in recent memory—the global COVID-19 pandemic.  Read More

Barney S. Graham, PhD'91, chief architect for the first experimental COVID-19 vaccine, will give the School of Medicine Basic Sciences Dean’s Lecture on Oct. 17 and be presented with the 2021 Distinguished Alumnus Award by Chancellor Daniel Diermeier. Read More

New Vanderbilt research explores the economic effects of pandemic-related migration patterns on municipal bonds. Read More

Dr. James Crowe, Robert Carnahan and their colleagues in the Vanderbilt Vaccine Center won the Gold medal in the 2022 R&D 100 awards for their discovery and development of long-acting antibodies that protect against COVID-19. The discovery of these antibodies has led to the development of Evusheld, pre-exposure therapy to prevent COVID-19 for adults and children over 12 with compromised immune systems or a history of severe adverse reactions to a COVID-19 vaccine. Read More

Vanderbilt continues to closely monitor COVID-19 and take precautions as needed to keep our community safe. The university offers numerous resources, which include providing students, postdocs, faculty and staff with on-campus and at-home testing options.  Read More

Vanderbilt University continues to provide all full-time, benefits-eligible staff members who are diagnosed with COVID-19 access to a paid leave bank of up to one week, equivalent to 40 hours of pay.  The bank is available to on-campus and remote workers who have been diagnosed and are symptomatic. Staff who are working remotely, diagnosed and isolating but are asymptomatic and able to perform their work should continue their normal remote work and are ineligible for the COVID-19 Leave Bank.   Read More

Vanderbilt University continues to work closely with public health experts at the university and Vanderbilt University Medical Center to ensure that its response to the COVID-19 pandemic is grounded in science and expert guidance with the goal of protecting community members.  Read More

The latest issue of the Peabody Journal of Education focuses on the pandemic’s consequences for equity and social justice, with insights on the PK-16 education system’s initial response to COVID-19 and how the first year of the pandemic affected education and educational inequality. Read More

A collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine. The group used multiple single-cell technologies, unbiased machine learning and traditional immunological approaches to track cellular and antibody responses in samples collected over time from a cohort of healthy participants. Read More

The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old. Read More

Students are most likely to benefit from online credit recovery when it blends online instruction with face-to-face time, rather than being conducted fully online, according to research published by Vanderbilt professor Carolyn J. Heinrich. Read More

The Vanderbilt University COVID-19 testing center at the David Williams II Recreation and Wellness Center will close operations for the summer, beginning May 16. Because of the reduced population and continued low positivity rates on campus, the asymptomatic testing program is also suspended. Read More

Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.   Read More

Changes in federal agencies’ procedures for designating nations’ level of travel risk will allow Vanderbilt’s Office of Global Safety to better communicate those risks to potential travelers connected with the university. Read More

Vanderbilt University professor Carolyn Heinrich and colleagues conducted research to examine interactions between people inquiring about how to get a COVID-19 vaccine with state agencies and major vaccination sites. Their findings are newly published online in the journal "Social Science & Medicine." Read More

The Vanderbilt University Symphony Orchestra and Vanderbilt's collegiate choirs will host a musical tribute to remember those who’ve suffered a loss during the COVID-19 pandemic. The concert will be on April 10 at 2 p.m. at the Martha Rivers Ingram Center for the Performing Arts at Vanderbilt Blair School of Music.  Read More

Some of Vanderbilt University’s leading experts on vaccines, infectious disease and public health came together for a special panel discussion on March 10 to talk about the future of the COVID-19 pandemic. The virtual event, “The COVID Conundrum: What’s Next,” was hosted by the Chancellor’s Lecture Series in partnership with the Vanderbilt School of Medicine Basic Sciences. Read More